Concepedia
Statistics
Publications
9
Citations
676
H-Index
Active since
1999
Affiliations
Adamas Pharmaceuticals (United States)(Current)
University of Kansas Medical Center
University of Toledo
University of Miami
Pfizer (United States)
Rajiv Patni is an author at Adamas Pharmaceuticals (United States).
Publications per year
1999–2019
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Murray Epstein, Gordon H. Williams, Myron H. Weinberger et al. · Clinical Journal of the American Society of Nephrology · 2006 · 453 citations
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
Lawrence Elmer, Jorge L. Juncos, Carlos Singer et al. · CNS Drugs · 2018 · 60 citations · Full text
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia
Robert A. Hauser, Rajesh Pahwa, William A. Wargin et al. · Clinical Pharmacokinetics · 2018 · 44 citations · Full text
Sustained Improvement in Flow-Mediated Vasodilation After Short-Term Administration of Dobutamine in Patients With Severe Congestive Heart Failure
M. B. Patel, Ilya V. Kaplan, Rajiv Patni et al. · Circulation · 1999 · 35 citations · Full text
Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials
Rajesh Pahwa, Stuart Isaacson, Joohi Jimenez‐Shahed et al. · Parkinsonism & Related Disorders · 2018 · 28 citations · Full text
1–5 of 9